Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

Mutations in the MEN1 gene are associated with the multiple endocrine neoplasia syndrome type 1 (MEN1), which is characterized by parathyroid hyperplasia and tumors of the pituitary and pancreatic islets. The mechanism by which MEN1 acts as a tumor suppressor is unclear. We have recently shown that menin, the MEN1 protein product, interacts with mixed lineage leukemia (MLL) family proteins in a histone methyltransferase complex including Ash2, Rbbp5, and WDR5. Here, we show that menin directly regulates expression of the cyclin-dependent kinase inhibitors p27^Kip1 and p18^Ink4c. Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27^Kip1 and p18^Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27^Kip1 and p18^Ink4c expression and deregulated cell growth. These findings suggest that regulation of cyclin-dependent kinase inhibitor transcription by cooperative interaction between menin and MLL plays a central role in menin's activity as a tumor suppressor.